Q2 26 EPS
$6.38
Q2 26 Revenue
$112.03B
vs S&P Since Q2 26
-4.4%
TRAILING MARKET
UNH -1.5% vs S&P +3.0%
Market Reaction
Did UNH Beat Earnings? Q2 2026 Results
UnitedHealth Group delivered a sharply stronger second quarter in 2026, posting earnings per share of $6.38 on revenue of $112.03 billion, up 0.4% from a year ago, as a dramatic recovery in profitability signaled that the company's cost discipline ef… Read more UnitedHealth Group delivered a sharply stronger second quarter in 2026, posting earnings per share of $6.38 on revenue of $112.03 billion, up 0.4% from a year ago, as a dramatic recovery in profitability signaled that the company's cost discipline efforts are taking hold. The most consequential driver was a meaningful improvement in the medical care ratio to 86.7% from 89.4% in Q2 2025, a swing that helped push consolidated operating earnings to $7.99 billion from $5.15 billion a year prior, aided by $860 million in net favorable prior period medical reserve development. That margin recovery stands in contrast to the elevated medical cost pressures weighing on several managed-care peers this earnings season. UnitedHealthcare's operating margin expanded to 4.6% from 2.4%, while Optum delivered 160 basis points of year-over-year margin improvement to 6.2%. Buoyed by the results, the company raised its full-year adjusted EPS outlook to $19.50 to $20.00 and lifted operating cash flow guidance to approximately $24.00 billion, doubling its share repurchase commitment to at least $5.00 billion.
Key Takeaways
- • Medical care ratio improvement to 86.7% from 89.4% year-over-year driven by benefit design, pricing discipline, member mix and medical cost management
- • $860 million net favorable prior period medical reserve development
- • Optum operating margin expansion of 160 basis points year-over-year to 6.2%
- • Strong operational improvements and medical cost management at Optum Health
- • Specialty generics adoption and operational improvements at Optum Rx
- • Cash flows from operations of $11.1 billion or 1.9x net income reflecting timing of substantial government payment
UNH Forward Guidance & Outlook
UnitedHealth Group raised its full year 2026 guidance. Adjusted EPS is now expected at $19.50 to $20.00 (up from prior floor of >$17.75). GAAP diluted EPS is expected at $18.45 to $18.95 (up from prior floor of >$17.10). Consolidated reported operating earnings are expected to exceed $25,450 million (up from >$24,000 million). The medical care ratio outlook improved to 88.1% ± 25 bps from 88.8% ± 50 bps. Cash flows from operations are now expected at approximately $24,000 million (up from >$18,000 million). Share repurchases are expected to be at least $5,000 million (up from ~$2,500 million). The tax rate is expected to be approximately 18.5%. Net earnings to UNH shareholders are expected to exceed $16,750 million.
UNH YoY Financials
Q2 2026 vs Q2 2025, source: SEC Filings
UNH Revenue by Segment
With YoY comparisons, source: SEC Filings
“Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people.”
— Stephen Hemsley, Q2 2026 Earnings Press Release
UNH Earnings Trends
UNH vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
UNH EPS Trend
Earnings per share: estimate vs actual
UNH Revenue Trend
Quarterly revenue: estimate vs actual
UNH Quarterly Results
6 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q2 26 | — | $6.38 | — | $112.03B | — |
| Q1 26 BEAT | $6.60 | $7.23 | +9.55% | $111.72B | +1.88% |
| Q4 25 BEAT FY | $2.11 | $2.11 | +0.00% | $113.22B | -0.37% |
| FY Full Year | $16.32 | $16.35 | +0.18% | $447.57B | -0.09% |
| Q3 25 BEAT | $2.81 | $2.92 | +3.91% | $113.16B | +0.09% |
| Q2 25 MISS | $4.45 | $4.08 | -8.31% | $111.62B | +0.03% |
| Q1 25 MISS | $7.29 | $7.20 | -1.23% | $109.58B | -1.82% |